California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on June 2, 2026

Jun. 2, 2026

JASI Skin + Wellness Med Spa Expands Skin of Color Specialty Treatments at Los Angeles Flagship

Indeterminate EIN Presswire

Jun. 2, 2026

INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q

Indeterminate GlobeNewswire

Jun. 2, 2026

Physicians Must Be Good Stewards of Their Practice, States the President of the Association of American Physicians and Surgeons (AAPS)

Indeterminate GlobeNewswire

Jun. 2, 2026

Moderna Launches Moderna Direct with “eCommerce Powered by FFF Enterprises™”

Indeterminate GlobeNewswire

Jun. 2, 2026

Alvotech to present at upcoming investor conferences in June

Indeterminate GlobeNewswire

Jun. 2, 2026

Onco360® Has Been Selected as a National Specialty Pharmacy Provider for IMKELDI® (imatinib) Oral Solution

Indeterminate GlobeNewswire

Jun. 2, 2026

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Tenaya Therapeutics to Announce New Interim Data from MyPEAK™-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated HCM on Wednesday, June 3, 2026

Indeterminate GlobeNewswire

Jun. 2, 2026

Neuronetics Appoints Robert Greene as Senior Vice President Sales

Indeterminate GlobeNewswire

Jun. 2, 2026

Nanobiotix Provides First Quarter 2026 Operational and Financial Update

Indeterminate GlobeNewswire

Jun. 2, 2026

Nanobiotix fait le point sur sa tresorerie et son activite operationnelle pour le premier trimestre 2026

Indeterminate GlobeNewswire

Jun. 2, 2026

Crescent Biopharma to Present at June Investor Conferences

Indeterminate GlobeNewswire

Jun. 2, 2026

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities

Indeterminate GlobeNewswire

Jun. 2, 2026

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results

Indeterminate GlobeNewswire

Jun. 2, 2026

Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution

Indeterminate GlobeNewswire

Jun. 2, 2026

Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults

Indeterminate GlobeNewswire